The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
As I wrote in my last note on Structure: The most famous examples of GLP-1 agonist drugs are Novo ... limited to sodium-glucose cotransporter-2 inhibitors. In such a crowded field of developers ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...
At the foundation of healthspan medicine are the pillars of health. These are easily understood through four simple verbs: ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
TNF Pharmaceuticals, Inc. ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, announced that data ...
For example, achieving just 5% market penetration ... While competitors like GLP-1s and PCSK9 inhibitors continue to dominate headlines, obicetrapib's oral convenience and targeted LDL-C lowering ...
Hua Medicine Announces 2024 Annual Results - HuaTangNing completed its first full year for reimbursement under the National Reimbursement D ...
11h
Trina Krug on MSNThe Ominous Octet – 8 Hidden Drivers of Type 2 DiabetesMany individuals are told that managing type 2 diabetes is simply a matter of controlling blood sugar. As long as glucos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results